Objective, Investment Banking & Valuation
Mandy Farris Woods, MBA, serves as the Chief Operating Officer and EOS Integrator at Objective, Investment Banking & Valuation since April 2017, leading a firm dedicated to Sell-Side M&A and Valuation Advisory Services for middle market companies. Previous experience includes roles as Executive Administrator at Ansun Biopharma, Inc. and Pediatric Bioscience, Inc., as well as positions in finance and administration at Search Optics and hospital administration at Palomar Health. Mandy has a comprehensive background in business operations, having started their career at Digital Gene Technologies, Inc. as an Executive Administrator and progressing through project management at Morrison & Foerster LLP. Mandy holds an MBA in Organizational Leadership and a BBA, magna cum laude, both from the University of Arizona, along with certificates in Human Resource Management and Accounting from UC San Diego.
This person is not in any teams
Objective, Investment Banking & Valuation
Objective, Investment Banking & Valuation (“Objective”) is a leading investment banking and valuation firm that services middle market companies within our industry practices: Business Services, Consumer, Healthcare Tech & Services, Life Sciences Services & Tech, Manufacturing & Distribution, and Technology. Within our industry practices we offer an investment banking group providing sell-side advisory, and a full-service valuation group providing tax compliance, financial reporting, transaction opinion, and strategic advisory services. Founded in 2006, Objective’s seasoned professionals have collectively executed over 500 M&A advisory engagements and thousands of business valuations throughout their careers. Our firm’s name embodies our core mission: to help business owners achieve their objectives. Both of our Investment Banking and Valuation groups have been recognized countless times including Best Investment Bank & Valuation Firm 2022 USA, Industrials Deal of The Year (Between $50MM - $100MM) 2022, Technology Deal of The Year (Between $10MM - $50MM) 2022, Valuation Firm of The Year 2022, and many more. Securities Products offered through BA Securities, LLC Member FINRA (www.FINRA.org) SIPC (www.SIPC.org). Objective Capital Partners and BA Securities LLC are separate, unaffiliated entities.